ReviewMedical sciences (Basel, Switzerland)2026
Exerkines During Pregnancy: Linking Maternal Exercise with Cardiometabolic Health-A Narrative Review.
Review in Medical sciences (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Physical exercise during pregnancy is associated with important maternal and foetal health benefits. These include reduced risks of gestational diabetes mellitus (GDM), hypertensive disorders of pregnancy (HDP), and excessive gestational weight gain. However, the molecular mechanisms underlying these benefits remain incompletely understood. Exerkines are exercise-responsive signalling molecules released from skeletal muscle and other metabolically active tissues and may contribute to metabolic, vascular, inflammatory, and mitochondrial adaptations. This narrative review critically examines current evidence linking exerkines with maternal exercise and cardiometabolic adaptation during pregnancy, with particular emphasis on GDM, HDP, maternal obesity, placental function, and maternal-placental-foetal communication. Evidence was identified through a comprehensive, iterative search of PubMed/MEDLINE, Scopus, and Web of Science primarily covering literature published between January 2016 and July 2026. Priority was given to human pregnancy studies and clinically relevant outcomes. Pregnancy-specific evidence is currently strongest for irisin, although findings remain heterogeneous. Acute exercise studies also indicate transient changes in circulating fibroblast growth factor 21. Evidence for β-aminoisobutyric acid, apelin, adiponectin, chemerin, and interleukin-6 is more limited and frequently relies on experimental or non-pregnant populations. Overall, current evidence supports exerkines as plausible contributors to the cardiometabolic adaptations associated with maternal exercise, but does not establish them as causal mediators. Their principal value at present lies in providing a biological framework linking established clinical benefits of prenatal exercise with metabolic, vascular, inflammatory, and placental adaptations, while identifying specific pathways that require confirmation in pregnancy-specific longitudinal and intervention studies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.